| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $210.00K | $210.00K | – | $512.00K |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $5.07M | $6.40M | $4.77M | $6.70M | $6.19M |
| SG&A | $6.63M | $7.43M | $6.29M | $7.17M | $7.07M |
| Operating Income | -$11.70M | -$13.83M | -$11.01M | -$13.88M | -$13.14M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$10.93M | -$12.55M | -$9.81M | -$13.60M | -$12.95M |
| EPS (basic) | -0.3400 | -0.3900 | 0.3200 | -0.4500 | -0.4500 |
| EPS (diluted) | -0.3400 | -0.3900 | 0.3200 | 0.4500 | – |
| Shares (diluted) | $32.45K | $31.90K | $30.98K | $30.37M | $28.58M |